Background: Hyperhomocysteinemia (Hhcy) occurs in about 85% of chronic kidney disease (CKD) patients because of impaired renal metabolism and reduced renal excretion. Folic acid (FA), the synthetic form of vitamin B9, is critical in the conversion of homocysteine (Hcy) to methionine. If there is not enough intake of FA, there is not enough conversion, and Hcy levels are raised.
Summary: Hhcy is regarded as an independent predictor of cardiovascular morbidity and mortality in end-stage renal disease. Hhcy exerts its pathogenic action on the main processes involved in the progression of vascular damage. Research has shown Hhcy suggests enhanced risks for inflammation and endothelial injury which lead to cardiovascular disease (CVD), stroke, and CKD. FA has also been shown to improve endothelial function without lowering Hcy, suggesting an alternative explanation for the effect of FA on endothelial function. Recently, the role of FA and Hhcy in CVD and in CKD progression was renewed in some randomized trials.
Key messages: In the general population and in CKD patients, it remains a topic of discussion whether any beneficial effects of FA therapy are to be referred to its direct effect or to a reduction of Hhcy. While waiting for the results of confirmatory trials, it is reasonable to consider FA with or without methylcobalamin supplementation as appropriate adjunctive therapy in patients with CKD.
Keywords: Cardiovascular disease; Chronic kidney disease; Folate pathway; Homocysteine; Hyperhomocysteinemia.
Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats.Microvasc Res. 2013 Sep;89:146-52. doi: 10.1016/j.mvr.2013.07.002. Epub 2013 Jul 13. Microvasc Res. 2013. PMID: 23859838
Association between hyperhomocysteinemia and stroke with atherosclerosis and small artery occlusion depends on homocysteine metabolism-related vitamin levels in Chinese patients with normal renal function.Metab Brain Dis. 2017 Jun;32(3):859-865. doi: 10.1007/s11011-017-9978-3. Epub 2017 Mar 6. Metab Brain Dis. 2017. PMID: 28261756
Homocysteine in Renal Injury.Kidney Dis (Basel). 2016 Jun;2(2):80-7. doi: 10.1159/000444900. Epub 2016 Apr 27. Kidney Dis (Basel). 2016. PMID: 27536696 Free PMC article. Review.
Homocysteine, cysteine, folate and vitamin B₁₂ status in type 2 diabetic patients with chronic kidney disease.J Nephrol. 2015 Oct;28(5):571-6. doi: 10.1007/s40620-014-0126-4. Epub 2014 Aug 6. J Nephrol. 2015. PMID: 25095762
The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice.Int J Mol Sci. 2019 Jan 8;20(1):231. doi: 10.3390/ijms20010231. Int J Mol Sci. 2019. PMID: 30626145 Free PMC article. Review.
Cited by 11 articles
Nitrative Stress-Related Autophagic Insufficiency Participates in Hyperhomocysteinemia-Induced Renal Aging.Oxid Med Cell Longev. 2020 Jan 25;2020:4252047. doi: 10.1155/2020/4252047. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32047576 Free PMC article.
Vitamin B2 and Folate Concentrations are Associated with ARA, EPA and DHA Fatty Acids in Red Blood Cells of Brazilian Children and Adolescents.Nutrients. 2019 Dec 2;11(12):2918. doi: 10.3390/nu11122918. Nutrients. 2019. PMID: 31810311 Free PMC article.
Effects of Long-Versus Short-Term Exposure to the Mediterranean Diet on Skin Microvascular Function and Quality of Life of Healthy Adults in Greece and the UK.Nutrients. 2019 Oct 16;11(10):2487. doi: 10.3390/nu11102487. Nutrients. 2019. PMID: 31623223 Free PMC article. Clinical Trial.
Anti-Tumor Effects of Vitamin B2, B6 and B9 in Promonocytic Lymphoma Cells.Int J Mol Sci. 2019 Aug 1;20(15):3763. doi: 10.3390/ijms20153763. Int J Mol Sci. 2019. PMID: 31374832 Free PMC article.
The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort.J Nephrol. 2019 Oct;32(5):783-789. doi: 10.1007/s40620-019-00618-x. Epub 2019 Jun 5. J Nephrol. 2019. PMID: 31165981